| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 01/29/2008 | 8:00AM | PR Newswire (US) | Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Co | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/18/2008 | 5:30PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Securities Registration Statement (simplified form) (S-3) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/11/2008 | 4:43PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/10/2008 | 5:27PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/31/2007 | 8:30AM | PR Newswire (US) | Ardea Biosciences' Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/28/2007 | 12:46PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Beneficial Ownership (SC 13D) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/21/2007 | 5:23PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/21/2007 | 4:58PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/21/2007 | 4:56PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/21/2007 | 4:49PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/21/2007 | 4:48PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/21/2007 | 4:46PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/21/2007 | 4:10PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/20/2007 | 4:41PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/20/2007 | 8:47AM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/20/2007 | 8:30AM | PR Newswire (US) | Ardea Biosciences Announces $40 Million Private Placement | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/14/2007 | 4:01PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/07/2007 | 8:00AM | PR Newswire (US) | Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/06/2007 | 5:02PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/06/2007 | 4:54PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/06/2007 | 2:29PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/05/2007 | 5:51PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/28/2007 | 8:01AM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/28/2007 | 8:00AM | PR Newswire (US) | Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/20/2007 | 8:00AM | PR Newswire (US) | Ardea Biosciences to Present at the Lazard Capital Markets Fourth Annual Health Care Conference | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/20/2007 | 8:00AM | PR Newswire (US) | Ardea Biosciences to Present at the Piper Jaffray 19th Annual Health Care Conference | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/14/2007 | 4:45PM | PR Newswire (US) | Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/14/2007 | 4:20PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Quarterly Report (10-Q) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/24/2007 | 2:40PM | PR Newswire (US) | New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |